In the treatment of pancreatic cancer, some studies have reported the progress of statins in inhibiting PDAC by targeting the P2X7-Akt axis or P3IK/Akt signal and making pancreatic cancer cells sensitive to chemotherapeutic drugs (Mistafa and Stenius, 2009; Mohammed et al., 2012). The gene discussed is AKT1; the disease is familial pancreatic carcinoma.